P9072 Pheresis Platelets HCPCS Reimbursement

HCPCS Level II code P9072 denotes a unit of pheresis platelets that has undergone pathogen reduction or rapid bacterial testing. This code identifies a higher-safety blood product used to reduce transfusion-transmitted infections and bacterial contamination risk in platelet transfusion. Nationally, the use of pathogen-reduced or rapidly tested platelets is an important patient-safety advance with implications for hospital blood management, supply chain logistics, and payer coverage policy.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise policy and billing overview, payer coverage considerations, and clinical context for use of pathogen-reduced or rapid bacterial-tested pheresis platelets. The publication also summarizes typical sites of service and the service line for which P9072 is billed.

This content provides benchmarks and comparative policy notes where available, highlights common billing and documentation points relevant to blood product supply, and outlines how P9072 fits into transfusion practice and hospital blood management. Data not available in the input are noted where applicable.

Billing Code Overview

HCPCS Level II code P9072 describes platelets, pheresis, pathogen reduced or rapid bacterial tested, each unit. The service type is blood product supply (pheresis platelets) with pathogen-reduction or rapid bacterial testing, typically provided as a transfusion product for patients requiring platelet support. Typical sites of service include hospital inpatient and outpatient transfusion centers, ambulatory infusion centers, and blood bank facilities.

Data not available in the input.

Clinical Context

A typical patient scenario involves an adult inpatient or outpatient receiving a transfusion of apheresis platelets that have undergone pathogen reduction or rapid bacterial testing. The patient may be hospitalized for chemotherapy-induced thrombocytopenia, hematologic malignancy, preparation for invasive procedures, or active bleeding with platelet dysfunction. The clinical workflow includes: initial order by the treating physician for platelet transfusion; blood bank selection and verification of P9072 units (pheresis platelets that are pathogen-reduced or have passed rapid bacterial testing); bedside verification of patient identity and transfusion consent; pre-transfusion vitals and compatibility checks; transfusion administration by nursing with monitoring for transfusion reactions; documentation of unit lot numbers and specific product attributes (pathogen-reduced or rapid bacterial-tested) in the medical record; and post-transfusion assessment of hemostatic response and potential adverse events. Typical sites of service are hospital inpatient wards, oncology infusion centers, ambulatory surgery centers when transfusion is required peri-procedurally, and outpatient transfusion clinics.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	When additional work or complexity is documented for transfusion beyond usual expectations (rare for blood product codes).

Taxonomy Code	Specialty	Notes
`207RH0004X`	Hematology & Medical Oncology	Physicians who frequently order and oversee platelet transfusions for malignancy and bone marrow suppression.
`207L00000X`	Anesthesiology	Providers involved when transfusion occurs perioperatively in surgical settings.
`363LA2200X`	Transfusion Medicine Specialist	Physicians or pathologists specializing in blood banking and transfusion practices.
`163W00000X`	Nurse Practitioner	Advanced practice providers who may manage transfusion orders and patient monitoring in outpatient clinics.
`164W00000X`	Physician Assistant	Clinicians who assist with transfusion management in hospitals and infusion centers.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`D69.5`	Secondary thrombocytopenia	Common indication for therapeutic platelet transfusion in patients with decreased platelet counts due to disease or treatment.
`D69.6`	Thrombocytopenia, unspecified	General diagnosis leading to platelet transfusion when platelet count is low or bleeding risk is high.
`C90.00`	Multiple myeloma not having achieved remission	Hematologic malignancies often cause thrombocytopenia requiring platelet support.
`C91.10`	Chronic lymphocytic leukemia of B-cell type not having achieved remission	Leukemias frequently require platelet transfusions during disease or treatment.
`D66`	Hereditary factor VIII deficiency (hemophilia A)	Patients with bleeding disorders may require platelet support for bleeding or procedures when platelets are dysfunctional.
`O72.3`	Postpartum hemorrhage, thrombocytopenia-related	Obstetric hemorrhage situations where platelet transfusion is clinically indicated.
`R58`	Hemorrhage, not elsewhere classified	Active bleeding events where platelet transfusion may be indicated to achieve hemostasis.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`36430`	Transfusion, blood; peripheral, includes infusion and post-transfusion monitoring	Often performed when administering platelet products—covers the transfusion event and monitoring by staff.
`36514`	Collection of apheresis units, plateletpheresis; peripheral venous catheter, with automated collection	Related to procurement of apheresis platelet units that will be pathogen-reduced or tested prior to issuance.
`86355`	Hematology test; platelet function analysis (eg, aggregometry)	May be used pre- or post-transfusion to assess platelet function in select patients.
`87070`	Culture, bacterial; any other source, aerobic/anaerobic, each organism isolated	Used for rapid bacterial testing or cultures when bacterial contamination is suspected in platelet units.
`99070`	Supplies and materials (eg, drugs, biologicals), noncovered under the primary procedure	May be used to bill for special supplies related to pathogen-reduction processing when permitted by payer policy.

OpenPayer

Summary & Overview

HCPCS P9072: Pheresis Platelets, Pathogen-Reduced or Rapid Bacterial Tested, Each Unit